Search
![](https://static.wixstatic.com/media/nsplsh_899b76e387744ea99cf392afa56d0e3a~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_899b76e387744ea99cf392afa56d0e3a~mv2.webp)
![EMA Guidance: EudraVigilance Registration Documents](https://static.wixstatic.com/media/nsplsh_899b76e387744ea99cf392afa56d0e3a~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_899b76e387744ea99cf392afa56d0e3a~mv2.webp)
Sharan Murugan
- May 18
- 2 min
EMA Guidance: EudraVigilance Registration Documents
The European Medicines Agency (EMA) on Thursday (16 May, 2024) released an updated guidance on "EudraVigilance Registration Documents"...
14 views0 comments
![](https://static.wixstatic.com/media/nsplsh_afdf029796e04569bf344970352b63a8~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_afdf029796e04569bf344970352b63a8~mv2.webp)
![South Africa's (SAPHRA): Guideline on Pharmacovigilance Systems](https://static.wixstatic.com/media/nsplsh_afdf029796e04569bf344970352b63a8~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_afdf029796e04569bf344970352b63a8~mv2.webp)
Sharan Murugan
- Jun 6, 2023
- 1 min
South Africa's (SAPHRA): Guideline on Pharmacovigilance Systems
Earlier today (06 June, 2023) the South African Health Products Regulatory Authority (SAPHRA) released an updated Guideline on...
29 views0 comments
![](https://static.wixstatic.com/media/nsplsh_adc921c26ca442dd9b1fb67fd674289f~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_adc921c26ca442dd9b1fb67fd674289f~mv2.webp)
![UK MHRA: Guidance on Qualified Person responsible for QPPV & PSMF](https://static.wixstatic.com/media/nsplsh_adc921c26ca442dd9b1fb67fd674289f~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_adc921c26ca442dd9b1fb67fd674289f~mv2.webp)
Sharan Murugan
- May 13, 2023
- 2 min
UK MHRA: Guidance on Qualified Person responsible for QPPV & PSMF
Last Thursday (11 May 2023) UK's Medicines and Healthcare Products Regulatory Agency (MHRA) released updated "Guidance on the qualified...
53 views0 comments
![](https://static.wixstatic.com/media/nsplsh_f6f2b85004314bb181a28ff898744c45~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_f6f2b85004314bb181a28ff898744c45~mv2.webp)
![Guidance on QPPV including Pharmacovigilance System Master Files– MHRA](https://static.wixstatic.com/media/nsplsh_f6f2b85004314bb181a28ff898744c45~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_f6f2b85004314bb181a28ff898744c45~mv2.webp)
Sharan Murugan
- Dec 5, 2021
- 2 min
Guidance on QPPV including Pharmacovigilance System Master Files– MHRA
UK Medicines and Healthcare products Regulatory Agency (MHRA) updated its guidance on requesting a pharmacovigilance system master file...
30 views0 comments